Emergence of undifferentiated urothelial carcinoma after pembrolizumab treatment for patient with invasive urothelial bladder cancer: A case report

An 83-year-old man received pembrolizumab treatment after anticancer chemotherapy with gemcitabine and cisplatin for advanced bladder cancer. Pathological findings revealed invasive urothelial carcinoma with squamous differentiation before treatment. After seven courses of pembrolizumab treatment, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasegawa, Moto, Hasegawa, Go, Ikeda, Yohei, Hara, Noboru, Nishiyama, Tsutomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294485/
https://www.ncbi.nlm.nih.gov/pubmed/32587697
http://dx.doi.org/10.1177/2050313X20932694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294485/
https://www.ncbi.nlm.nih.gov/pubmed/32587697
http://dx.doi.org/10.1177/2050313X20932694

Ejemplares similares